[A randomized comparison of carvedilol and metoprolol in patients with chronic heart failure. The Carvedilol Or Metoprolol European Trial (COMET)]

Ugeskr Laeger. 2004 Aug 2;166(32):2671-4.
[Article in Danish]
No abstract available

Publication types

  • Clinical Trial
  • Comparative Study
  • Randomized Controlled Trial

MeSH terms

  • Adrenergic beta-Antagonists / administration & dosage
  • Adrenergic beta-Antagonists / adverse effects
  • Adrenergic beta-Antagonists / therapeutic use*
  • Aged
  • Carbazoles / administration & dosage
  • Carbazoles / adverse effects
  • Carbazoles / therapeutic use*
  • Carvedilol
  • Double-Blind Method
  • Female
  • Follow-Up Studies
  • Heart Failure / drug therapy*
  • Heart Failure / mortality
  • Humans
  • Male
  • Metoprolol / administration & dosage
  • Metoprolol / adverse effects
  • Metoprolol / therapeutic use*
  • Propanolamines / administration & dosage
  • Propanolamines / adverse effects
  • Propanolamines / therapeutic use*
  • Survival Rate

Substances

  • Adrenergic beta-Antagonists
  • Carbazoles
  • Propanolamines
  • Carvedilol
  • Metoprolol